These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19043728)

  • 1. The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.
    van Hooren AC; Brouwer J; de Bree R; Hoekstra OS; Leemans CR; Uyl-de Groot CA
    Eur Arch Otorhinolaryngol; 2009 Sep; 266(9):1441-8. PubMed ID: 19043728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of recurrent laryngeal tumor after radiotherapy using (18)FDG-PET as initial method.
    Brouwer J; de Bree R; Comans EF; Akarriou M; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Radiother Oncol; 2008 May; 87(2):217-20. PubMed ID: 18329117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.
    de Bree R; van der Putten L; van Tinteren H; Wedman J; Oyen WJ; Janssen LM; van den Brekel MW; Comans EF; Pruim J; Takes RP; Hobbelink MG; Valdés Olmos R; van der Laan BF; Boers M; Hoekstra OS; Leemans CR
    Radiother Oncol; 2016 Feb; 118(2):251-6. PubMed ID: 26477395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of dual-head 18F-fluorodeoxyglucose PET for the detection of recurrent laryngeal cancer.
    Bongers V; Hobbelink MG; van Rijk PP; Hordijk GJ
    Cancer Biother Radiopharm; 2002 Jun; 17(3):303-6. PubMed ID: 12136522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?
    Wedman J; Pruim J; van der Putten L; Hoekstra OS; de Bree R; van Dijk BAC; van der Laan BFAM
    Clin Otolaryngol; 2019 Mar; 44(2):124-130. PubMed ID: 30315624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of PET scanning to improve diagnostic yield of direct laryngoscopy in patients with suspicion of recurrent laryngeal carcinoma after radiotherapy.
    de Bree R; van der Putten L; Hoekstra OS; Kuik DJ; Uyl-de Groot CA; van Tinteren H; Leemans CR; Boers M;
    Contemp Clin Trials; 2007 Nov; 28(6):705-12. PubMed ID: 17459783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose (FDG) in patients with suspicion of recurrent laryngeal carcinoma].
    Alvarez Pérez RM; Borrego Dorado I; Vázquez Albertino R; Ruiz Franco-Baux J; Ceballo Pedraja JM; Esteban Ortega F
    Acta Otorrinolaringol Esp; 2006 Mar; 57(3):134-9. PubMed ID: 16615566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography.
    Stokkel MP; Terhaard CH; Hordijk GJ; van Rijk PP
    Eur J Nucl Med; 1999 Jul; 26(7):767-73. PubMed ID: 10398825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer.
    Terhaard CH; Bongers V; van Rijk PP; Hordijk GJ
    Head Neck; 2001 Nov; 23(11):933-41. PubMed ID: 11754496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
    Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
    J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]FLT-PET and [18F]FDG-PET in the evaluation of radiotherapy for laryngeal cancer.
    Been LB; Hoekstra HJ; Suurmeijer AJ; Jager PL; van der Laan BF; Elsinga PH
    Oral Oncol; 2009 Dec; 45(12):e211-5. PubMed ID: 19692292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.
    van der Putten L; Hoekstra OS; de Bree R; Kuik DJ; Comans EF; Langendijk JA; Leemans CR
    Mol Imaging Biol; 2008 Sep; 10(5):294-303. PubMed ID: 18622649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma.
    Yen RF; Yen MF; Hong RL; Tzen KY; Chien CR; Chen TH
    Acad Radiol; 2009 Jan; 16(1):54-60. PubMed ID: 19064212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting recurrent laryngeal carcinoma after radiotherapy: room for improvement.
    Brouwer J; Bodar EJ; De Bree R; Langendijk JA; Castelijns JA; Hoekstra OS; Leemans CR
    Eur Arch Otorhinolaryngol; 2004 Sep; 261(8):417-22. PubMed ID: 14625779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer.
    Kim HJ; Boyd J; Dunphy F; Lowe V
    Clin Nucl Med; 1998 Nov; 23(11):750-2. PubMed ID: 9814562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy.
    Brouwer J; Hooft L; Hoekstra OS; Riphagen II; Castelijns JA; de Bree R; Leemans CR
    Head Neck; 2008 Jul; 30(7):889-97. PubMed ID: 18213716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
    Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
    Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorine-18-FDG detection of laryngeal cancer postradiotherapy using dual-head coincidence imaging.
    Stokkel MP; Terhaard CH; Mertens IJ; Hordijk GJ; van Rijk PP
    J Nucl Med; 1998 Aug; 39(8):1385-7. PubMed ID: 9708513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma.
    Périé S; Hugentobler A; Susini B; Balogova S; Grahek D; Kerrou K; Montravers F; Chater PE; St Guily JL; Talbot JN
    Otolaryngol Head Neck Surg; 2007 Oct; 137(4):647-53. PubMed ID: 17903585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.